论文信息 - Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in Asia. - 字舞流文

Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in Asia.

K. Muro | Y. Cheng | S. Qin | Z. Li | K. Gu | T. Liu | S. Lee | C. Hsu | Y. Fan | S. Kim | Y. Cheng | J. Zhang | T. Liu | X. Yin | L. Bai | Y. Cao | J. Chen | Y. Cui | S. Luo | Y. Sun | X. Yuan | W. Li | X. Lin | T. Kojima | Y. Bai | T. Doi | C. Bai | H. Pan | J-W Yang | W. Lu